Intense pulsed light (IPL) technology has the potential to revolutionize dry eye management and ocular surface disease.
Artificial intelligence (AI) may hold the answers to some of the biggest challenges in optometry, according to Nahida Akter, PhD; Jack Phu, OD, PhD, FAAO; and Christopher Clark, OD, PhD, at the 2019 American Academy of Optometry meeting i
Halting glaucoma progression can be challenging, but as it turns out, medication is not the only tool in an OD’s toolbox. Many factors influence glaucoma progression in patients, some of which may be unrelated to the disease itself.
Optometry doesn’t play a great enough role in the long-term management of chronic disease globally.
Hybrid contact lenses are an innovative yet challenging way to improve patient vision.
How many ODs embrace technology?
Eye care is an ever-evolving field, and 2019 brought with it several advances in approach and technique that surgeons need to keep in mind as they adopt the latest best practices in glaucoma surgery.
Meibomian gland dysfunction (MGD) may be misdiagnosed. While MGD is one of the most common chronic ocular conditions, diagnosing MGD isn’t as simple as it seems.
Not all situations can be handled within one office, so sometimes it is necessary to refer patients elsewhere. Despite the logic behind them, referrals often come bundled with liabilities that can give any OD a headache.
Stem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference.